BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23179809)

  • 1. [Preservatives in ophthalmology].
    Messmer EM
    Ophthalmologe; 2012 Nov; 109(11):1064-70. PubMed ID: 23179809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular preservatives: associated risks and newer options.
    Kaur IP; Lal S; Rana C; Kakkar S; Singh H
    Cutan Ocul Toxicol; 2009; 28(3):93-103. PubMed ID: 19505226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A correct understanding of preservatives in eye drops].
    Liu Z; Huang C
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):641-4. PubMed ID: 26693647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic preservatives: focus on polyquaternium-1.
    Rolando M; Crider JY; Kahook MY
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis with use of eye-drops containing benzalkonium chloride preservative.
    Anderson D; Faltay B; Haller NA
    Clin Exp Optom; 2009 Sep; 92(5):444-6. PubMed ID: 19549228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicity research status of benzalkonium chloride on ocular surface].
    Huang C; Chen W; Chen Y; Liu Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):303-6. PubMed ID: 24931157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of common ophthalmic preservatives on ocular health.
    Noecker R
    Adv Ther; 2001; 18(5):205-15. PubMed ID: 11783457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservatives in eyedrops: the good, the bad and the ugly.
    Baudouin C; Labbé A; Liang H; Pauly A; Brignole-Baudouin F
    Prog Retin Eye Res; 2010 Jul; 29(4):312-34. PubMed ID: 20302969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservative-free treatment in glaucoma: who, when, and why.
    Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
    Eur J Ophthalmol; 2013; 23(4):518-25. PubMed ID: 23483513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological alterations induced by preservatives in eye drops].
    Huber-van der Velden KK; Thieme H; Eichhorn M
    Ophthalmologe; 2012 Nov; 109(11):1077-81. PubMed ID: 23179812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.
    Hsu KH; Gupta K; Nayaka H; Donthi A; Kaul S; Chauhan A
    Pharm Res; 2017 Dec; 34(12):2862-2872. PubMed ID: 29067592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork.
    Izzotti A; La Maestra S; Micale RT; Longobardi MG; Saccà SC
    Mutat Res; 2015 Feb; 772():1-9. PubMed ID: 25772104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiglaucoma drops--with or without preservatives].
    Zemba M
    Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservatives in ophthalmic topical medications: a significant cause of disease.
    Olson RJ; White GL
    Cornea; 1990 Oct; 9(4):363-4. PubMed ID: 2078969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preservatives in eye drops: toward awareness of their toxicity].
    Vaede D; Baudouin C; Warnet JM; Brignole-Baudouin F
    J Fr Ophtalmol; 2010 Sep; 33(7):505-24. PubMed ID: 20832141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the toxicity profile of benzalkonium chloride-preserved tafluprost and SofZia-preserved travoprost applied to the ocular surface.
    Kanamoto T; Kiuchi Y; Tanito M; Mizoue S; Naito T; Teranishi S; Hirooka K; Rimayanti U;
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):156-64. PubMed ID: 25710276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.
    Coroi MC; Bungau S; Tit M
    Rom J Ophthalmol; 2015; 59(1):2-5. PubMed ID: 27373107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergy to ophthalmic preservatives.
    Hong J; Bielory L
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):447-53. PubMed ID: 19697451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.